Unmet Treatment Need in a Real World US Population of Patients with Hereditary Angioedema Treated for Over a Year with Long Term Prophylaxis

Ionis Pharmaceuticals Inc. published this content on February 27, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on February 27, 2026 at 12:13 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]